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Abstract Ataxin-1 is the protein responsible for the
genetically-inherited neurodegenerative disease spinocere-
bellar ataxia type-1 linked to the expansion of a polyglu-
tamine tract within the protein sequence. The AXH domain
of ataxin-1 is essential for the protein to function as a
transcriptional co-repressor and mediates the majority of
the interactions of ataxin-1 with cellular partners, mainly
transcriptional regulators. One of the best characterized
ataxin-1 functional partners is Capicua (CIC), a transcrip-
tional repressor involved in signalling pathways that reg-
ulate mammalian development, tumorigenesis and, through
the interaction with ataxin-1, also neurodegeneration.
Complex formation of ataxin-1 with CIC is important both
for the function of the wild-type protein and for patho-
genesis as transcriptional disregulation is observed since
the early stages of the development of the disease. Here we
report the 1H, 13C and 15N backbone and side-chain
chemical shift assignments of the human ataxin-1 AXH
domain in complex with a CIC ligand-peptide.
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Biological context
Ataxin-1 is the protein associated with the human neuro-
degenerative spinocerebellar ataxia type 1 or SCA1
(de Chiara and Pastore 2011; Orr et al. 1993; Zoghbi and
Orr 2009). The protein belongs to the family of the
so-called polyglutamine proteins, all related to neurode-
generation, in which pathogenesis is associated with the
expansion of a CAG repeat tract in the coding region of the
gene. Although the disease is triggered by the elongation of
the polyglutamine tract, which determines protein aggre-
gation, it is now generally accepted that the protein context
may modulate this process. Indeed, regions distant in
sequence from the polyglutamines and interactions with
molecular partners have been shown to play a role, either
positive or negative, in modifying the pathology (de Chiara
et al. 2009; Masino et al. 2011). One of such regions is the
AXH domain of ataxin-1, which has been shown to con-
tribute to aggregation of the expanded and non-expanded
full length ataxin-1 in cells and to be sufficient to form
fibres in vitro when isolated (de Chiara et al. 2005). The
AXH domain of ataxin-1 is essential for the protein to
function as a transcriptional co-repressor and mediates the
majority of the interactions of ataxin-1 with cellular part-
ners, mainly transcriptional regulators. The domain, which
shares an oligonucleotide-binding fold and crystallizes as a
dimer of asymmetric dimers, has been shown to be pre-
dominantly dimeric in solution and in equilibrium with
monomers, tetramers and higher molecular weight species
(de Chiara et al. 2013). The involvement of the domain in
multiple association states and the presence of an extensive
asymmetry at the interface between monomers are reflected
in a very complex NMR spectrum which has hampered any
possibility of achieving a complete resonances assignment
of the free form of the domain (de Chiara et al. 2013).
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Interestingly, upon interaction with the ligand-peptide from
CIC (L-CICp) the AXH domain forms a monomeric 1:1
complex with an NMR spectrum indicative of a single
species (Fig. 1). Here we report the practically complete
assignment of the complex between human ataxin-1 AXH
and CIC.
Materials and methods
Protein expression and purification
The recombinant AXH domain of human ataxin-1 (residues
A567–K689) was over-expressed in the E. coli host strain
BL21 (DE3) using a kanamycin-resistant pETM30 vector
with a TEV-cleavable N-terminal His6-GST tag. Isotopi-
cally 15N- and 13C/15N-labelled samples were expressed in
minimal (M9) medium supplemented with 15N-ammonium
sulphate and 13C-glucose as the sole sources of nitrogen
and carbon respectively. Purification was performed using
a Ni–NTA agarose column (Qiagen) followed by FPLC
size exclusion chromatography as previously described (de
Chiara et al. 2003). A synthetic unlabelled ligand peptide
L-CICp spanning the sequence V34-Q48 of human CIC
was purchased from Pepceuticals Limited (Nottingham-
UK). AXH domain and L-CICp peptide concentrations were
measured by UV absorbance at 280 nm using a calculated
extension coefficient of 8,480 and 5,500 M-1 cm-1,
respectively.
NMR spectroscopy
NMR spectra for resonance assignments were acquired on
samples containing 15N- or 15N,13C-labelled ATX1 AXH
(0.5 mM) and unlabelled L-CICp (0.6 mM) (AXH:L-CICp
molar ratio 1:1.2) in 20 mM Tris–HCl pH 6.85, 2 mM
TCEP, 0.02 % NaN3, 8 % 2H2O. The spectra were recor-
ded at 300 K using Varian Inova spectrometers operating
at 600 and 800 MHz 1H frequency, the 800 MHz equipped
with a triple resonance gradient Cold-Probe, and Bruker
Avance spectrometers operating at 600 and 700 MHz 1H
frequency, both equipped with triple resonance gradient
CryoProbes.
All spectra were processed using NMRPipe/NMRDraw
softwares (Delaglio et al. 1995) and analyzed using
XEASY (Bartels et al. 1995).
Resonance assignment and Deposition
Assignment of 1H, 13C and 15N of the AXH domain bound
to unlabelled L-CICp was obtained as described below.
Sequence specific 1HN, 15N, 13Ca, 13Cb and 13C assign-
ment for the AXH were obtained using HNCA,
HN(CO)CA, HNCO and HNCACB (Muhandiram and Kay
1994) in combination with a 3D 15N-edited NOESY-HSQC
experiment. Assignments of the 1H and 13C resonances of
AXH aliphatic and aromatic side chains were obtained
from HCCH-TOCSY experiments tuned for the two dis-
tinct regions of the spectrum (Sattler et al. 1999). Aromatic
sequence specific side chain assignments were achieved
using (Hb)Cb(CcCd)Hd and (Hb)Cb(CcCd)He spectra
supported by the identification of main-chain/side-chain
NOEs from the 13C-edited NOESY-HSQC spectrum
(100 ms mixing time). The proton resonances assignment
of the CIC ligand-peptide was achieved using a combina-
tion of 2D [15N,13C]-F1/F2-filtered NOESY (mixing time
100 ms) and TOCSY (Otting and Wuthrich 1990). We
assigned 100 % of the HN and N, 97 % of C and 96 % of
H resonances of the backbone atoms and the side chains.
No residues were completely unassigned.
Secondary structure predicted on the base of the
chemical shifts using Talos? (Shen et al. 2009) and CSI
Fig. 1 2D 1H, 15N-HSQC spectrum of ataxin1 AXH domain in
complex with unlabelled L-CICp (AXH:L-CIC-p ratio 1:1.2) recorded
at 300 K on a Varian-Inova 800 MHz spectrometer. Side chains of
glutamines and asparagines are indicated by a connecting line
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(version 2.0) (Wishart and Sykes 1994) for the protein and
the peptide, respectively, have been compared with those
of the complex and of the X-ray structure of the free form
(Fig. 2). The 1H, 13C and 15N chemical shift of the ataxin-1
AXH domain and the 1H chemical shifts of the CIC ligand
peptide have been deposited into the BioMagResBank
database and are available under the BMRB accession
number 18982.
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